Table 1.
Thyroid cancer staging
| Parameter | Patients % (n = 42) | % |
|---|---|---|
| ATA 2015 recurrence risk | ||
| Low | 17 | 40 |
| Intermediate | 25 | 60 |
| Initial tumor staging after surgery | ||
| Tumor staging | ||
| T1a | 2 | 5 |
| T1b | 6 | 14 |
| T2 | 12 | 29 |
| T3 with tumor size>40 mm | 5 | 12 |
| T3 with extra thyroid extension | 17 | 40 |
| Lymph node staging | ||
| N0 | 17 | 40 |
| N1a | 12 | 29 |
| N1b | 5 | 12 |
| Nx | 8 | 19 |
| Metastatic staging during follow-up | ||
| M0 | 42 | 100 |
| M1 | 0 |
American Joint Committee on Cancer (AJCC) 7th edition of the TNM classification system for differentiated thyroid carcinoma was used to establish TNM staging in the study. ATA, American Thyroid Association.